yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q35197507-6CAE3E8B-B116-4B97-8203-A3D050BF4C05
Q35197507-6CAE3E8B-B116-4B97-8203-A3D050BF4C05
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35197507-6CAE3E8B-B116-4B97-8203-A3D050BF4C05
MEK inhibitor PD-0325901 overcomes resistance to CK2 inhibitor CX-4945 and exhibits anti-tumor activity in head and neck cancer.
P2860
Q35197507-6CAE3E8B-B116-4B97-8203-A3D050BF4C05
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35197507-6CAE3E8B-B116-4B97-8203-A3D050BF4C05
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e53c7852715bdb50593a4e7dfcf154a2bb025e7e
P2860
CX-4945, an orally bioavailable selective inhibitor of protein kinase CK2, inhibits prosurvival and angiogenic signaling and exhibits antitumor efficacy.